We are on the cusp of a revolution in genetics. The cost of sequencing a genome has tumbled, DNA testing has become routine and new technologies such as CRISPR are allowing us to edit the code of life ...

In recent years, the U.S. Food and Drug Administration has approved more than a dozen gene-editing and cell-based therapies. We are now in the second great wave of the genetic revolution, not defined ...

Better data collection and NHS backup is needed for day when it will be cost-effective to carry out whole genome tests on patients ...

Genetic testing to find DNA markers of genetic diseases, like cystic fibrosis and cancer, has been around since the 1960s and '70s. But Johns Hopkins Medicine notes that just in the last decade, there ...